Guggenheim Adjusts Price Target on Biogen to $255 From $275
MT NewswiresApr 26 23:27
Analysts Offer Insights on Healthcare Companies: Biogen (BIIB), Dexcom (DXCM) and Herbalife (HLF)
TipRanksApr 26 17:50
Buy Rating Justified: Biogen's Promising Drug Launches and Strategic Growth Initiatives
TipRanksApr 26 14:22
Biogen's Financial Upswing: Strong Q1 Performance and Market Penetration Justify Buy Rating
TipRanksApr 26 13:58
Barclays: Maintaining the Biogen (BIIB.US) rating, adjusted from a shareholding wait-and-see rating to a shareholding wait-and-see rating, and the target price was adjusted from $215.00 to $200.00.
Zhitong FinanceApr 26 02:10
Biogen Analyst Ratings
BenzingaApr 26 02:01
HC Wainwright Adjusts Biogen's Price Target to $300 From $325
MT NewswiresApr 25 19:39
Truist Financial Reaffirms Their Buy Rating on Biogen (BIIB)
TipRanksApr 25 19:10
Wedbush Adjusts Price Target on Biogen to $215 From $213
MT NewswiresApr 25 18:48
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (TMO), Biogen (BIIB) and Molina Healthcare (MOH)
TipRanksApr 25 17:40
Biogen Analyst Ratings
BenzingaApr 25 17:31
RBC Lowers Biogen's Price Target to $317 From $326
MT NewswiresApr 25 01:25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Humana (HUM), Boston Scientific (BSX) and Biogen (BIIB)
TipRanksApr 24 21:10
Needham: Reiterates Biogen (BIIB.US) rating and adjusted from buy to buy rating, target price is $294.00.
Zhitong FinanceApr 24 20:41
Biogen Analyst Ratings
BenzingaApr 24 20:32
Needham Reiterates Buy on Biogen, Maintains $294 Price Target
BenzingaApr 24 20:34
Analysts Offer Insights on Healthcare Companies: Day One Biopharmaceuticals (DAWN), Biogen (BIIB) and Neurocrine (NBIX)
TipRanksApr 24 17:42
Piper Sandler Sticks to Its Buy Rating for Biogen (BIIB)
TipRanksApr 22 20:28
Biogen Analyst Ratings
BenzingaApr 19 22:51
Analysts Are Bullish on These Healthcare Stocks: Gilead Sciences (GILD), Biogen (BIIB)
TipRanksApr 19 19:50
No Data
No Data